Loading...
•
Jun 30, 2023
3D Systems Q2 2023 Earnings Report
3D Systems reported a decrease in revenue due to lower sales in the dental orthodontics market, while also seeing growth in non-dental markets and investing in regenerative medicine.
Key Takeaways
3D Systems reported a decrease in revenue for Q2 2023, primarily due to lower sales in the dental orthodontics market. However, the company saw growth in non-dental markets and continued to invest in regenerative medicine. They are adjusting their full-year 2023 revenue expectation to $525 million to $545 million and anticipate positive adjusted EBITDA in Q4 2023.
Revenue decreased by 8.5% to $128.194 million compared to the same period last year, with a decrease of 8.7% on a constant currency basis.
The decline in revenue primarily reflects lower sales to certain dental orthodontic market customers due to macroeconomic factors.
Healthcare Solutions revenue decreased by 15.2% to $60.874 million compared to the same period last year, while Industrial Solutions revenue decreased by 1.4% to $67.320 million.
The company is adjusting its full-year 2023 revenue expectation to $525 million to $545 million and expects positive adjusted EBITDA in Q4 2023.
Revenue by Segment
Forward Guidance
3D Systems is revising its full-year 2023 revenue expectation to $525 million to $545 million, and would now expect positive adjusted EBITDA in Q4’23. This includes the full year investment of roughly $10 million in our regenerative medicine business.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...